➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Moodys
Merck

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

CIRCANOL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Circanol patents expire, and when can generic versions of Circanol launch?

Circanol is a drug marketed by 3M and is included in two NDAs.

The generic ingredient in CIRCANOL is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.

US ANDA Litigation and Generic Entry Outlook for Circanol

A generic version of CIRCANOL was approved as ergoloid mesylates by SUN PHARM INDUSTRIES on October 31st, 1991.

  Start Trial

Summary for CIRCANOL
US Patents:0
Applicants:1
NDAs:2
Formulation / Manufacturing:see details
DailyMed Link:CIRCANOL at DailyMed
Drug patent expirations by year for CIRCANOL

US Patents and Regulatory Information for CIRCANOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m CIRCANOL ergoloid mesylates TABLET;SUBLINGUAL 084868-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
3m CIRCANOL ergoloid mesylates TABLET;SUBLINGUAL 085809-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Moodys
Mallinckrodt
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.